Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Congenital Heart Disease Studies, Cardiac Valve Diseases and Treatments, and Venous Thromboembolism Diagnosis and Management.
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Covered Stent Correction for Sinus Venosus Atrial Septal Defects, an Emerging Alternative to Surgical Repair: Results of an International Registry
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function
Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension
Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
Portopulmonary hypertension in the current era of pulmonary hypertension management
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Initial dual oral combination therapy in pulmonary arterial hypertension
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial
Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis